Navigation Links
Ontario Institute for Cancer Research Validates NEBNext(TM) DNA Sample Preparation Reagents from New England Biolabs for use in Next Generation Sequencing
Date:9/29/2009

IPSWICH, Mass., Sept. 29 /PRNewswire/ -- Dr. John McPherson, Platform Leader, Cancer Genomics and High-Throughput Screening, and Dr. Kamran Shazand, Project Manager, of the Ontario Institute for Cancer Research (OICR) led a team of scientists who have completed a thorough evaluation of the NEBNext(TM) DNA Sample Prep Reagents for use with OICR's Illumina® Genome Analyzer II. Dr. McPherson said of the evaluation, "We are constantly striving for the best quality sequencing results at a price that does not restrict our throughput needs and NEB's new reagents meet this need well."

(Logo: http://www.newscom.com/cgi-bin/prnh/20090921/NE79207LOGO-b )

"We are extremely pleased that OICR, as a world leading genome center, has determined that our reagents meet their high standards," stated Dr. Peter Nathan, Director of Global Business Development at New England Biolabs.

NEBNext(TM) DNA Sample Prep Reagent Sets contain enzymes and buffers that are ideally suited for sample preparation for next generation sequencing, and for preparation of expression libraries. Reagents are available for each step of the library construction workflow, including end repair, dA-tailing, adapter ligation and amplification. These sets are highly cost effective and each of the components must pass rigorous quality control and validation, including independent third-party evaluation on the appropriate NGS platform.

About New England Biolabs (NEB)

Established in the mid 1970's, New England Biolabs, Inc. leads the industry in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genome research. NEB continues to expand its product offerings into areas related to PCR, cloning, expression and purification, and is focusing on strengthening alliances that enable new technologies to reach key market sectors. New England Biolabs is a privately held company headquartered in Ipswich, MA and has extensive worldwide distribution through a network of exclusive distributors, agents and five subsidiaries located in Canada, China, Germany, Japan and the UK. For more information about New England Biolabs visit (http://www.neb.com)

About Ontario Institute for Cancer Research (OICR)

The Ontario Institute for Cancer Research is a new innovative cancer research centre, moving Ontario to the forefront of discovery and innovation. It is dedicated to research in prevention, early detection, diagnosis and treatment of cancer. OICR is a not-for-profit corporation funded by the Government of Ontario through the Ministry of Research and Innovation. For more information about OICR, visit (http://www.oicr.on.ca)

SOURCE New England Biolabs


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Nanocopoeia Licenses New Polymer-Based Biomaterials Platform From the University of Western Ontario
2. Sparking Growth In Ontarios Biopharmaceutical Industry
3. Senate President Therese Murray, Massachusetts Life Sciences Center, and Howard Hughes Medical Institute Join Marine Biological Laboratory (MBL) for Loeb Laboratory Groundbreaking Ceremony
4. CELLECTA, INC. to Develop New Approach for Cancer Gene Discovery in Partnership with Roswell Park Cancer Institute and Health Research, Inc.
5. HUYA Bioscience Establishes First-Look Agreement With Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences (GIBH)
6. SRA International Wins $16 Million Contract from Cancer Prevention and Research Institute of Texas
7. Pacific Health Research Institute Awarded $2.8 Million in Research Funding
8. Pacific Health Research Institute Awarded $2.8 Million in Research Funding
9. Bayer CropScience Announces Investment of $25 Million for Institute Site
10. Korea Institute of Toxicology Implementing Xybion's Pristima™
11. K-States Biosecurity Research Institute Gives Researchers the Tools Needed to Study Diseases That Cost Pig Producers Hundreds of Millions of Dollars Each Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... This CAST literature review and report looks at problems caused ... the economic effects in countries that are major global commodity exporters and importers, which ... risk of low level presence (LLP) puts large volumes of trade worth billions of ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016 Soligenix, ... biopharmaceutical company focused on developing and commercializing products to ... need, announced today that it will be hosting an ... am ET on the origins of innate defense regulators ... a review of oral mucositis and the recently announced ...
(Date:12/8/2016)... 2016 Savannah River Remediation LLC group ... NewTechBio,s NT-MAX Lake & Pond Sludge and ... in conjunction with Hexa Armor/ Rhombo cover manufactured ... Pollutant Discharge Elimination System requirements. The ... history of elevated pH levels, above 8.5, especially ...
(Date:12/8/2016)... 2016  Partnering to fuel Philadelphia,s ... of Southeastern Pennsylvania (" Ben ... of Independence Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... a $6 million funding initiative over a four year ... Responding to a burgeoning economic vitality in digital health, ...
Breaking Biology Technology:
(Date:12/7/2016)... , Dec. 7, 2016   Avanade is ... Formula One teams in history, exploit biometric data in ... performance and maintain the competitive edge against their rivals ... Avanade has worked with Williams during ... of biometric data (heart rate, breathing rate, temperature and ...
(Date:12/5/2016)... , Dec. 5, 2016  The Office ... today published "Can CT Scans Enhance or Replace ... the potential of supporting or replacing forensic autopsies ... CT scan. In response to recommendations ... is exploring using CT scans as a potential ...
(Date:11/29/2016)... BioDirection, a privately held medical device company developing novel ... concussion and other traumatic brain injury (TBI), announced today ... the U.S. Food and Drug Administration (FDA) to review ... meeting company representatives reviewed plans for clinical development of ... a planned pilot trial. "We are ...
Breaking Biology News(10 mins):